Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Children's Healthcare of Atlanta |
---|---|
Information provided by: | Children's Healthcare of Atlanta |
ClinicalTrials.gov Identifier: | NCT00215098 |
The purpose of this study is to determine at risk populations for certain congenital heart defects or certain operative procedures and to define the associated morbidity secondary to chylothorax - prolonged chest tube drainage, prolonged hospital stay, need for central access and hyperalimentation, subsequent infection.
Condition |
---|
Chylothorax |
Study Type: | Observational |
Study Design: | Natural History, Longitudinal, Defined Population, Retrospective Study |
Official Title: | Chylothorax in Children Following Congenital Heart Surgery |
Estimated Enrollment: | 70 |
Study Start Date: | May 2005 |
Estimated Study Completion Date: | November 2006 |
Chylothorax is not uncommon following congenital heart surgery. It often results in prolonged chest tube drainage and hospital stays. Due to the feeding difficulties, it often results in malnutrition and the need for central hyperalimentation. In addition, it results in a depressed immune system with the possibility of subsequent infection. Chylothorax can be a significant contributor to post-operative morbidity and mortality.
The primary aims are to determine at risk populations - certain congenital heart defects or certain operative procedures, to define the associated morbidity secondary to chylothorax - prolonged chest tube drainage, prolonged hospital stay, need for central access and hyperalimentation, subsequent infection and to review our current treatment methods - change formulas, hyperalimentation, somatostatin. The secondary aims are to determine ways to prevent chylothorax, determine the most successful treatment method, and to discover better treatment methods. This study will be conducted through a retrospective chart review.
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
-
United States, Georgia | |
Children's Healthcare of Atlanta at Egleston | |
Atlanta, Georgia, United States, 30322 |
Principal Investigator: | Brian Kogon, MD | Emory University |
Study ID Numbers: | 05-093 |
Study First Received: | September 20, 2005 |
Last Updated: | June 12, 2007 |
ClinicalTrials.gov Identifier: | NCT00215098 |
Health Authority: | United States: Food and Drug Administration |
pediatric health cardiac congenital heart surgery |
post-operative chylous effusions heart defects children |
Respiratory Tract Diseases Pleural Diseases Chylothorax |